Iqvia Holdings, Inc. · NYSE:IQV
Iqvia — IQVIA Research Forum 2022
14 slides from Iqvia's conference presentation, October 2022
Slide 1: IQVIA Research Forum 2022
IQVIA Research Forum 2022 P a t h w a ys a n d P r i o r i t i e s f o r H i g h I m p a c t Health Research October 2022 Copyright © 2019 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States and various other countries.
Slide 2: IQVIA Institute contributes to advancing human health through rigorous research
IQVIA Institute for Human Data Science contributes to advancing human health by generating rigorous, evidence-based research PROPRIETARY DATA SOURCES* LIBRARY OF REPORTS EVIDENCE- SUBJECT MATTER EXPERTS BASED RESEARCH CONFERENCES ADVANCED ANALYTICAL SKILLS AND FORUMS THIRD PARTY INFORMATION PEER-REV
Slide 3: Support for academic researchers
Support for academic researchers How researchers can benefit from IQVIA data IQVIA data assets frequently used in academic research Through collaboration with the IQVIA Institute, Formulary Impact Analyzer: Pharmacy claims with insight into paid, rejected researchers have access to a broad range of
Slide 4: Pathways and Priorities for High Impact Health Research
Pathways and Priorities for High Impact Health Research IQVIA Research Forum 2022 Incorporating Navigating the Exploring the Elevating the the impact of complexity elusive nature value to Charting the social and of applied heterogeneity patients of future of high determinants research in of patient
Slide 5: Navigating the complexity and heterogeneity of patient affordability and access
Navigating the complexity and heterogeneity of patient affordability and access 4
Slide 6: What do affordability and access mean in a diverse population?
What do affordability and access mean in a diverse population? Framing some high-level questions for our panelists Defining affordability – the ‘to whom’ question If we don’t know what it is, how do we measure if we’re addressing it? What evidence is critical in evaluating affordability and access t
Slide 7: Over 92% of prescriptions have a final out-of-pocket cost below $20
Over 92% of prescriptions have a final out-of-pocket cost below $20, 1% (64 million) prescriptions have costs above $125 Distribution of prescriptions by out-of-pocket cost in 2021, all channels All prescriptions: brands and generics Brands only 92% 1% 73% 4% $500+ All payers $250-$499.99 $125-$249.
Slide 8: Overall, 8% of patients reach annual out-of-pocket costs above $500
Overall, 8% of patients reach annual out-of-pocket costs above $500 compared to 16% in Medicare largely due to benefit design Patients by annual prescription out-of-pocket cost in 2021 $1,500+ 8% All payers 29% $1,250-$1,499.99 234Mn $1,000-$1,249.99 $750-$999.99 16% Medicare 22% 42Mn $500-$749.99 $
Slide 9: Patients of diverse racial and ethnic backgrounds experience cost differently
Patients of diverse racial and ethnic backgrounds are experiencing cost in the health system differently Fewer non-White patients use copay cards, but users are more exposed to CAP programs Difference in Likelihood of Copay Card Use and CAP Exposure, Non-White Patients, Adjusted (Ref: White; Commerc
Slide 10: Today's panelists
Today’s panelists Ernst (Ernie) Berndt, Ph.D. Stacie Dusetzina, Ph.D. Professor, Applied Economics Associate Professor, Health Policy MIT Sloan School of Management Vanderbilt University Medical Center Rena Conti, Ph.D. Richard Frank, Ph.D. Associate Professor, Markets, Public Senior Fellow, Economi
Slide 11: Q&A
Q&A Post your questions and comments in the Q&A box 10
Slide 12: 2022 Research Forum Agenda
2022 Research Forum Agenda Incorporating Navigating the Exploring the Elevating the the impact of complexity elusive nature value to Charting the social and of applied heterogeneity patients of future of high determinants research in of patient academic impact health on outcomes national health affo
Slide 13: Download featured Institute content
Download featured Institute content www.IQVIAInstitute.org Find us on social media Twitter: @IQVIA_Institute LinkedIn: #IQVIAInstitute 12
Slide 14: Thank you
Thank you Global Trends in R&D: Overview through 2020. Report by the IQVIA Institute for Human Data Science.